Newtyn Management’s Passage Bio PASG Stock Holding History

Newtyn Management’s Portfolio PASG Stock Details PASG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-33,261	Closed	-$637K	–	69
2023 Q1	$637K	Sell	33,261 -6,239	-16%	-$169K	0.13%	66
2022 Q4	$1.09M	Buy	39,500 +24,500	+163%	+$618K	0.23%	49
2022 Q3	$375K	Sell	15,000 -16,000	-52%	-$631K	0.08%	69
2022 Q2	$1.46M	Buy	+31,000	New	+$1.45M	0.28%	51

Other funds holding PASG

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

VVM

Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return

BCM

BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

LCM

Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Newtyn Management's PASG Position: Q2 2023 in Review

Newtyn Management sold out of Passage Bio (PASG) in Q2 2023, closing a stake of 33,261 shares — an estimated $637K sold.

Newtyn Management first reported a position in PASG in Q2 2022 and held it in 4 quarters. The position peaked at $1.46M in Q2 2022. 54 funds tracked by Wall St. Rank hold PASG as of Q2 2023.

Newtyn Management reported no remaining Passage Bio position as of Q2 2023 after selling out during the quarter.
Newtyn Management sold 33,261 Passage Bio shares in Q2 2023, an estimated $637K.
Newtyn Management first reported a position in Passage Bio in Q2 2022 and held it in 4 quarters.
Newtyn Management's Passage Bio position peaked at $1.46M in Q2 2022.
54 funds tracked by Wall St. Rank held Passage Bio as of Q2 2023.

Based on Newtyn Management's 13F filing for Q2 2023, filed 14 Aug 2023.